What is the Impact Factor of Neuropsychiatric Disease and Treatment?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Neuropsychiatric Disease and Treatment is 3.20, ranking in quartile Q2 of Web of Science (SCIE).

Is Neuropsychiatric Disease and Treatment indexed in Web of Science or Scopus?

Yes, Neuropsychiatric Disease and Treatment is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.947 (Q2) and an H-index of 106.

Who publishes Neuropsychiatric Disease and Treatment and what is the Article Processing Charge (APC)?

Neuropsychiatric Disease and Treatment is published by Dove Medical Press Ltd.. The estimated Article Processing Charge (APC) is approximately $3,234 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Neuropsychiatric Disease and Treatment?

The official ISO-4 abbreviation of Neuropsychiatric Disease and Treatment is "NEUROPSYCHIATR. DIS. TREAT". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #5,342Hybrid

Neuropsychiatric Disease and Treatment

Abbreviation (ISO):NEUROPSYCHIATR. DIS. TREAT

•

Identifier (ISSN):1176-6328(Print)/1178-2021(Online)

•

Publisher:Dove Medical Press Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

3.2↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Neuropsychiatric Disease and Treatment

WoS Q2

Annual Impact Factor Metric

Current (2026):3.2

Scopus SJR & RankScopus Q2

0.947

#5,342

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

106

106 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

322articles/year

98.91% Gold OA•83.27% Original Research

Aims & Scope

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

Topics Covered (Recognized by AI)

Medicine97.4%Psychology90%Psychiatry85%Biology84.7%Internal medicine80%Neuroscience58.9%Pathology55.6%Endocrinology41.7%Clinical psychology36.7%Chemistry33.5%Cognition33.5%Computer science32%Biochemistry31.1%Genetics29.9%Mathematics29.5%Statistics26.7%Pharmacology25.3%Anxiety24%Surgery23.8%Economics23.6%Social psychology22.3%Programming language20.4%

Primary Research Areas

Clinical Neurology Psychiatry

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CLINICAL NEUROLOGY

Rank117/296

IndexSCIE

JCRSCIE2026

PSYCHIATRY

Rank103/293

IndexSCIE

JCISCIE2026

CLINICAL NEUROLOGY

Rank129/296

IndexSCIE

JCISCIE2026

PSYCHIATRY

Rank132/293

IndexSCIE

Category	Index	Rank	Quartile
CLINICAL NEUROLOGY	JCRSCIE	117/296	Q2
PSYCHIATRY	JCRSCIE	103/293	Q2
CLINICAL NEUROLOGY	JCISCIE	129/296	Q2
PSYCHIATRY	JCISCIE	132/293	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.2

Articles / Year147

Total Citations32

2025

IF2.9

Articles / Year218

Total Citations506

2024

IF2.5

Articles / Year228

Total Citations1,214

2023

IF3.2

Articles / Year249

Total Citations2,654

2022

IF2.989

Articles / Year271

Total Citations3,653

Year	Impact Factor	Articles / Year	Total Citations
2026	3.2	147	32
2025	2.9	218	506
2024	2.5	228	1,214
2023	3.2	249	2,654
2022	2.989	271	3,653
2021	2.57	351	5,950
2020	2.157	325	9,559
2019	—	335	8,427
2018	—	358	10,626
2017	—	332	10,328
2016	—	375	13,906
2015	—	338	13,336

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,342Scopus Q2SCImago Profile

Scopus Coverage:2001, 2006-2026

•

Scopus Broad Areas:MedicineNeuroscience

Scopus Citation Rank (SJR)Q2

0.947

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

3.10

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,234 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,469

3-Year Documents723

Citable Documents687

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Psychiatry and Mental HealthQ2

Biological PsychiatryQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区CLINICAL NEUROLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Neuropsychiatric Disease and Treatment (abbr: NEUROPSYCHIATR. DIS. TREAT, ISSN: 1176-6328) is a peer-reviewed international scholarly journal in the field of CLINICAL NEUROLOGY, published by Dove Medical Press Ltd. in New Zealand since 2005. The periodical holds a Journal Impact Factor (JIF) of 3.20, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.947 (Q2), an H-index of 106.

The journal enforces rigorous peer evaluation with an annual output of approximately 322 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,234 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.